Home › Funds › Sarissa Capital Management LP › VOR

Sarissa Capital Management LP position in VOR

VOR BIOPHARMA INC COM NEW · Health Care

Sarissa Capital Management LP reported holding 25,399 shares of VOR (VOR BIOPHARMA INC COM NEW) in its Q2 2026 13F filing — a position valued at US$468K, representing 0.26% of its reported portfolio and ranking #9 among its reported holdings. Sarissa Capital Management LP has disclosed VOR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)25.40K sh
Reported value held$467.60K
Portfolio Weight0.26%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sarissa Capital Management LP's VOR position evolved

Sarissa Capital Management LP first disclosed a stake in VOR in Q3 2023 at 618,000 shares (US$1.3M). The position peaked in Q1 2024 at 618,000 shares, worth US$1.5M. Across 12 filings, Sarissa Capital Management LP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 9 time(s). The most recent filing (Q2 2026) shows 25,399 shares valued at US$468K. Notable position changes include a 95% trim in Q3 2025 (shares fell 73% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 618.00K $1.31M New
Q4 2023 618.00K $1.39M Hold
Q1 2024 618.00K $1.46M Hold
Q2 2024 618.00K $618.00K Hold
Q3 2024 618.00K $432.60K Hold
Q4 2024 618.00K $685.98K Hold
Q1 2025 508.02K $364.50K Reduce
Q2 2025 508.02K $822.99K Hold
Q3 2025 25.40K $1.24M Reduce
Q4 2025 25.40K $332.22K Hold
Q1 2026 25.40K $453.12K Hold
Q2 2026 25.40K $467.60K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VOR and 13F data

VOR (VOR BIOPHARMA INC COM NEW) is a Health Care company. 75 other funds we track also report a position in VOR — the largest reported positions include TCG Crossover Management, LLC (US$104.4M), FCPM III SERVICES B.V. (US$75.8M), Venrock Adviser, LLC (US$56.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VOR

All VOR fund holders →

FAQ

How long has Sarissa Capital Management LP held VOR?

Sarissa Capital Management LP has disclosed VOR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Sarissa Capital Management LP's current position in VOR?

As of Q2 2026, Sarissa Capital Management LP holds 25.40K shares of VOR (VOR BIOPHARMA INC COM NEW), valued at $467.60K, representing 0.26% of its reported portfolio and ranking #9.

Has Sarissa Capital Management LP been buying or selling VOR?

In the latest 13F filing (Q2 2026), Sarissa Capital Management LP held unchanged its position in VOR. The position peaked in Q1 2024 at 618.00K shares.

Which other funds hold VOR?

Other major institutional holders of VOR include TCG Crossover Management, LLC, FCPM III SERVICES B.V., Venrock Adviser, LLC, among 75 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.